ALEXANDRIA, Va., Feb. 17 -- United States Patent no. 12,552,848, issued on Feb. 17, was assigned to Board of Regents of the University of Nebraska (Lincoln, Neb.) and San Diego State University Research Foundation (San Diego).
"Hydrochloride salts of C5a receptor agonist peptides" was invented by Sam D. Sanderson (Omaha, Neb.) and Edward Leroy Morgan (San Diego).
According to the abstract* released by the U.S. Patent & Trademark Office: "Hydrochloride salt forms of synthetic C-terminal peptide analogs of C5a, which are response selective agonists of C5aR-bearing antigen presenting cells. Methods of inducing an immune response in a subject by administering such peptide analogs alone or in combination with other active agents are also discl...